What is the level of liabilities of Organo this year?
Organo has a debt balance of 80.78 B JPY this year.
Organo Liabilities 2024
Organo Liabilities
80.78 B JPY
Ticker
6368.T
ISIN
JP3201600008
In 2024, Organo's total liabilities amounted to 80.78 B JPY, a 47.75% difference from the 54.67 B JPY total liabilities in the previous year.
Organo Aktienanalyse
What does Organo do?
Organo Corp is an internationally operating company specialized in the production and distribution of products in the health and wellness industry. The company was founded in Vancouver, Canada in 2008 by Bernardo Chua. Organo Corp's business model is based on network marketing to sell its products. This has allowed the company to quickly build a large customer base and become active in over 50 countries. The goal of Organo Corp is to help every customer lead a healthier and happier life. Organo Corp is divided into different divisions to offer customers a wide range of products. One of the main divisions is "Organo Gold," which offers coffee and tea products. These products are based on traditional Asian herbs and fungi such as Reishi, Ganoderma, and Cordyceps. These herbs have many active ingredients that strengthen the immune system, increase energy levels, reduce stress, and promote overall well-being. Another division of Organo Corp is "Organo Essentials," which offers products for a healthy everyday life. This includes supplements such as multivitamin tablets, protein powder, and Omega-3 fatty acids. These supplements are made from high-quality ingredients and aim to improve overall well-being. Organo Corp also has a "Personal Care" division, which offers products for personal hygiene. These include soaps, shampoos, creams, and lotions. These products contain natural ingredients such as tea tree oil, aloe vera, shea butter, and various essential oils that are intended to nourish and protect the skin. The company also has an "Organo Graphics" division, which offers marketing materials to help independent distributors of Organo Corp build their own business. This includes brochures, business cards, and sales tools. Organo Corp has also made a name for itself through various philanthropic activities. The company has established the "OG Care Foundation," which advocates for disadvantaged children and their families worldwide. The foundation supports projects in the areas of education, health, and well-being. In summary, Organo Corp is a company specializing in the sale of products in the health and wellness industry. The company offers a wide range of products based on natural ingredients such as Asian herbs and fungi. Through network marketing, Organo Corp has quickly built a large customer base and is now active in over 50 countries. Additionally, the company is committed to supporting disadvantaged children around the world through the "OG Care Foundation." Organo ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Organo's Liabilities
Organo's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Organo's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Organo's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Organo's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Organo’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Organo stock
What were the liabilities of Organo compared to the previous year?
The liabilities of Organo have increased by 47.75% increased compared to the previous year.
What are the consequences of high debt for investors of Organo?
High liabilities can pose a risk for investors of Organo, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Organo?
Low liabilities mean that Organo has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Organo affect the company?
An increase in liabilities of Organo can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Organo affect the company?
A decrease in the liabilities of Organo can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Organo?
Some factors that can influence the liabilities of Organo include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Organo so important for investors?
The liabilities of Organo are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Organo take to modify the liabilities?
To change its liabilities, Organo can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Organo pay?
Over the past 12 months, Organo paid a dividend of 114 JPY . This corresponds to a dividend yield of about 1.85 %. For the coming 12 months, Organo is expected to pay a dividend of 118.51 JPY.
What is the dividend yield of Organo?
The current dividend yield of Organo is 1.85 %.
When does Organo pay dividends?
Organo pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of Organo?
Organo paid dividends every year for the past 23 years.
What is the dividend of Organo?
For the upcoming 12 months, dividends amounting to 118.51 JPY are expected. This corresponds to a dividend yield of 1.92 %.
In which sector is Organo located?
Organo is assigned to the 'Industry' sector.
Wann musste ich die Aktien von Organo kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Organo from 12/1/2024 amounting to 53 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
When did Organo pay the last dividend?
The last dividend was paid out on 12/1/2024.
What was the dividend of Organo in the year 2023?
In the year 2023, Organo distributed 74 JPY as dividends.
In which currency does Organo pay out the dividend?
The dividends of Organo are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Organo
Our stock analysis for Organo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Organo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
